Homepage
What we do
Who are we?
The Cardiovascular Society ( Mauritius ) is a national cardiac society with interest in cardiovascular medicine.
It was founded on the 12th December 2012 and regroups the majority of cardiologists and cardiothoracic and vascular surgeons of Mauritius.
Learn More
Recent Conference
World Health Day 2021
Dates: September 25th-26th 2021
Venue:CRYSTAL BEACH MARITIM HOTEL - BELLE MARE
The Cardiovascular Society, in collaboration with the World Heart Federation,
CapeTown AFCentre & Wellkin Hospital
Learn More
Recent Conference
CardioMeet 2020 Mauritius
Dates: March 7th-8th 2020
Venue: Hilton Mauritius Resort & Spa
The Cardiovascular Society of Mauritius, the Hatter Cardiovascular Institute,UK and the University College London presents
The 2nd Edition in Africa!
Learn More
Recent Conference
CardioMeet 2019 Mauritius
Dates: February 2nd-3rd 2019
Venue: Le Meridien Hotel, Pointe aux Piments
A joint Cardiovascular Society Mauritius and European Society of Cardiologists.
The First ever in Africa!
Learn More
Stay connected
The latest developments in cardiology
Coming soon: links to latest technology in Cardiology, available both in Mauritius and Internationally
Search
Please fill keywords in text box and select particular category to search for past or future conferences
Cardiology News
- November 25, 2021Anticoagulants Can Ease Cognitive Decline in AF Patients
The adequate use of anticoagulants can prevent cognitive decline in elderly patients with atrial fibrillation, new Brazilian research shows. Medscape Medical News - November 24, 2021Daily Aspirin Linked to Increased Risk of Heart Failure
New data from a follow-up of more than 30,000 participants without heart failure at enrollment suggests that daily use of aspirin is associated with new onset heart failure. Medscape Medical News - November 24, 2021No Serious CV Risks for Elderly After Pfizer COVID-19 Vaccine
A French study adds to other evidence that the Pfizer mRNA COVID-19 vaccine does not increase the risk for serious cardiovascular adverse events in elderly individuals. Medscape Medical News - November 24, 2021At What Price Will Newer Anti-Diabetes Drugs Be Cost Effective?
In low- to middle-income countries, SGLT2 inhibitors could reduce diabetes complications at lower but feasible prices; they are cost effective at current prices in people with heart or kidney disease. Medscape Medical News - November 24, 2021Obicetrapib: CETP Inhibitor Impresses in LDL Lowering
A new lipid-lowering agent in a class that had been written off by many is being developed by a group of academic experts, with new data showing large LDL reductions on top of high-intensity statins. Medscape Medical News